Filing Details

Accession Number:
0001708138-21-000085
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-17 16:02:53
Reporting Period:
2021-11-15
Accepted Time:
2021-11-17 16:02:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1411984 P Daniel Plew Van 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp & General Mgr, Industrial No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-15 25,000 $270.43 51,931 No 4 M Direct
Common Stock Disposition 2021-11-15 18,222 $641.50 33,709 No 4 F Direct
Common Stock Disposition 2021-11-16 528 $652.20 33,181 No 4 S Direct
Common Stock Disposition 2021-11-16 840 $653.41 32,341 No 4 S Direct
Common Stock Disposition 2021-11-16 1,260 $654.33 31,081 No 4 S Direct
Common Stock Disposition 2021-11-16 350 $655.03 30,731 No 4 S Direct
Common Stock Disposition 2021-11-16 200 $657.18 30,531 No 4 S Direct
Common Stock Disposition 2021-11-16 697 $658.50 29,834 No 4 S Direct
Common Stock Disposition 2021-11-16 2,403 $659.42 27,431 No 4 S Direct
Common Stock Disposition 2021-11-16 500 $660.51 26,931 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2021-11-15 25,000 $0.00 25,000 $270.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-12-13 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,048 Indirect By 401(k) Plan
Footnotes
  1. Represents volume-weighted average price of sales of 528 shares of Company stock on November 16, 2021 at prices ranging from $652.01 to $652.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  2. Represents volume-weighted average price of sales of 840 shares of Company stock on November 16, 2021 at prices ranging from $653.03 to $653.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  3. Represents volume-weighted average price of sales of 1,260 shares of Company stock on November 16, 2021 at prices ranging from $654.03 to $654.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  4. Represents volume-weighted average price of sales of 350 shares of Company stock on November 16, 2021 at prices ranging from $655.01 to $655.07. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  5. Represents volume-weighted average price of sales of 200 shares of Company stock on November 16, 2021 at prices ranging from $657.09 to $657.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  6. Represents volume-weighted average price of sales of 697 shares of Company stock on November 16, 2021 at prices ranging from $658.03 to $658.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  7. Represents volume-weighted average price of sales of 2,403 shares of Company stock on November 16, 2021 at prices ranging from $659.01 to $659.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  8. Represents volume-weighted average price of sales of 500 shares of Company stock on November 16, 2021 at prices ranging from $660.33 to $660.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  9. The stock option award vests in four equal annual installments, commencing one year after the date of grant.